These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 28974744

  • 1. Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.
    Delanaye P, Warling X, Moonen M, Smelten N, Jouret F, Krzesinski JM, Maillard N, Pottel H, Cavalier E.
    Sci Rep; 2017 Oct 03; 7(1):12623. PubMed ID: 28974744
    [Abstract] [Full Text] [Related]

  • 2. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Oct 03; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

  • 3. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E, González Parra E, de la Piedra C, Caramelo C, Rapado A.
    Miner Electrolyte Metab; 1994 Oct 03; 20(5):259-64. PubMed ID: 7700213
    [Abstract] [Full Text] [Related]

  • 4. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep 03; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

  • 5. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
    Jean G, Souberbielle JC, Granjon S, Lorriaux C, Hurot JM, Mayor B, Deleaval P, Chazot C.
    Nephrol Ther; 2013 Jun 03; 9(3):154-9. PubMed ID: 23545236
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH, Davenport DL, Cantor T, Monier-Faugere MC.
    Clin J Am Soc Nephrol; 2014 Jul 03; 9(7):1254-62. PubMed ID: 24948144
    [Abstract] [Full Text] [Related]

  • 7. Bone markers during acute burn care: Relevance to clinical practice?
    Rousseau AF, Damas P, Delanaye P, Cavalier E.
    Burns; 2017 Feb 03; 43(1):176-181. PubMed ID: 27576929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S, Restituto P, Monreal I, Colina I, Calleja A, Varo N.
    J Clin Endocrinol Metab; 2013 Nov 03; 98(11):E1740-8. PubMed ID: 24001743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I, Balon BP, Rus I, Marc J.
    Nephrol Dial Transplant; 2005 Mar 03; 20(3):566-70. PubMed ID: 15665031
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S, Ishimura E, Tsuboniwa N, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Mori K, Nishizawa Y, Inaba M.
    Osteoporos Int; 2013 Feb 03; 24(2):605-12. PubMed ID: 22581293
    [Abstract] [Full Text] [Related]

  • 14. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
    Małyszko J, Wołczyński S, Małyszko JS, Konstantynowicz J, Kaczmarski M, Myśliwiec M.
    Transplant Proc; 2003 Jun 03; 35(4):1351-4. PubMed ID: 12826157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of Aerobic Exercise on Markers of Bone Metabolism of Overweight and Obese Patients With Chronic Kidney Disease.
    Gomes TS, Aoike DT, Baria F, Graciolli FG, Moyses RMA, Cuppari L.
    J Ren Nutr; 2017 Sep 03; 27(5):364-371. PubMed ID: 28606422
    [Abstract] [Full Text] [Related]

  • 17. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 Sep 03; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.
    Kidney Int; 2000 Feb 03; 57(2):423-36. PubMed ID: 10652019
    [Abstract] [Full Text] [Related]

  • 19. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N.
    Int Urol Nephrol; 2018 Dec 03; 50(12):2279-2288. PubMed ID: 30361964
    [Abstract] [Full Text] [Related]

  • 20. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
    Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W.
    J Clin Endocrinol Metab; 2007 Feb 03; 92(2):443-9. PubMed ID: 17105843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.